Stock Ratings / Health Care / BMY / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Bristol-Myers Squibb Company (BMY) 12-Month Stock Forecast & Price Target Cone

$61.39 +1.35% NYSE • Public Delayed / 60s Snapshot

Bristol-Myers Squibb Company (BMY) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (63/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+185.6% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $125.40B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS TUG-OF-WAR:59% Call Buyers ($13.3M)

41% PutsMax Pain: $60.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your BMY Position Size: $10,000

Shares at $61.39: 162.9 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $48.96

$7,975

$-2,025 (-20.2%)

12M Consensus BaseTarget $62.77

$10,225

+$225 (+2.2%)

12M Bull Case BreakoutTarget $74.07

$12,065

+$2,065 (+20.7%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$65	74%	A
Goldman SachsSector Coverage Lead	BUY	$70	69%	B
JP MorganUS Large-Cap Research	HOLD	$56	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BMY)

✓Live walkthrough of BMY's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

BMY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +3.12%▲ ASCENDING CHANNEL

2026-10-30O $63.00H $64.05L $62.29C $62.48VOL 12.67M

RES: $72.74SUP: $56.59SMA50: $62.80SMA200: $59.95

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BMY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BMY Butterfly Map → + Track BMY →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

10.9%/yr Implied 5Y Growth

vs. -0.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BMY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BMY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BMY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

BMY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is BMY's 12-month stock price target?

Bristol-Myers Squibb Company (BMY) carries a 12-month consensus base price target of $62.77 (+2.2% from $61.39), with a bull-case target of $74.07 and a bear-case floor of $48.96.

Is BMY stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates BMY D+ (Sell — SELL) with an RQD Confidence score of 63/100.

Direct Sub-Reports: BMY RQD Cockpit BMY 12M Forecast BMY Earnings & Move BMY Dividends & DRIP BMY Insiders & 13F BMY Whale Options BMY Profit Sankey BMY News & Why